Igene Biotechnology Inc (IGNE)

Igene Biotechnology Inc. is a common stock listing on OTC Markets under the symbol IGNE. The company focuses on researching, developing, producing, and commercializing specialty ingredients used in human and animal nutrition. Its product activity includes natural astaxanthin, a pigment source used in the coloring of farmed salmon and trout, as well as ingredients and finished products for the nutraceutical and feed industries. In addition to its ingredient business, Igene Biotechnology provides research and development services related to microbial strain improvement and fermentation process development, ranging from shake-flask work to pilot-scale and commercial fermentors. The company also offers analytical chemistry services for carotenoid identification and quantification in foods, feeds, and animal tissues, including testing that helps distinguish wild from farm-raised salmonids. Founded in 1981 and based in Columbia, Maryland, the company was previously known as IGI Biotechnology, Inc. before adopting its current name in 1986.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-IGNE
Not available
Not available
Not available
Fair
0.0%
1.564 K
Valuation • Fair Value

Igene Biotechnology Inc (OTC-IGNE) Fair Value by Valuation Model

No usable valuation estimate is currently available for Igene Biotechnology Inc (OTC-IGNE); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Igene Biotechnology Inc (OTC-IGNE). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Igene Biotechnology Inc (OTC-IGNE)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Igene Biotechnology Inc (OTC-IGNE) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Igene Biotechnology Inc (OTC-IGNE)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Igene Biotechnology Inc (OTC-IGNE). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Igene Biotechnology Inc (OTC-IGNE)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Igene Biotechnology Inc (OTC-IGNE). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Igene Biotechnology Inc (OTC-IGNE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Igene Biotechnology Inc (OTC-IGNE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Igene Biotechnology Inc (OTC-IGNE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Igene Biotechnology Inc (OTC-IGNE) Stock FAQ

Data-supported answers about Igene Biotechnology Inc (OTC-IGNE), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Fair
Current financial-health read

A reliable fair value estimate is not currently available for Igene Biotechnology Inc (OTC-IGNE). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Igene Biotechnology Inc (OTC-IGNE) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Igene Biotechnology Inc (OTC-IGNE).

The current market capitalization listed for Igene Biotechnology Inc is 1.564 K.

The ticker symbol for Igene Biotechnology Inc is OTC-IGNE, and the stock is listed on OTC Markets.

Igene Biotechnology Inc (OTC-IGNE) is listed on OTC Markets.